XML 47 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financial Statements - Statements of changes in equity - EUR (€)
Total
Capital
Share premium (*)
Equity instruments issued other than capital
Other Equity
Retained earnings
Revaluation reserves
Other reserves
Treasury shares [Member]
Profit or loss attributable to owners of the parent Member
Interim dividends Member
Accumulated other Comprehensive Income [Member]
Non-Controlling interests- Valuation Adjustments
Non-Controlling interests- Rest
Total Member
Balance at beginning at Dec. 31, 2016   € 3,218,000,000 € 23,992,000,000 € 0 € 54,000,000 € 23,688,000,000 € 20,000,000 € (67,000,000) € (48,000,000) € 3,475,000,000 € (1,510,000,000) € (5,458,000,000) € (2,246,000,000) € 10,310,000,000 € 55,428,000,000
Changes in Equity Abstract                              
Adjustments Of Accounting Policies Applications   0 0 0 0 (1,813,000,000) 0 7,000,000 0 82,000,000 (111,000,000) 1,836,000,000 817,000,000 (817,000,000) 0
TOTAL RECOGNIZED INCOME/EXPENSES € 318,000,000 0 0 0 0 0 0 0 0 3,514,000,000 0 (3,317,000,000) (1,122,000,000) 1,243,000,000 318,000,000
Changes in equity                              
Total Changes in Equity   50,000,000 0 0 0 1,872,000,000 (8,000,000) 25,000,000 (48,000,000) (3,557,000,000) 449,000,000 0 0 (1,207,000,000) (2,423,000,000)
Issue Of Equity   50,000,000 0 0 0 (50,000,000) 0 0 0 0 0 0 0 0 0
Issuances of preferred shares   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuance of other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Period or maturity of other issued equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Conversion of debt on equity   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock reduction   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividend distribution   0 0 0 0 9,000,000 0 (9,000,000) 0 0 (1,029,000,000) 0 0 (290,000,000) (1,318,000,000)
Purchase of treasury shares   0 0 0 0 0 0 0 (1,674,000,000) 0 0 0 0 0 (1,674,000,000)
Sale or cancellation of treasury shares   0 0 0 0 1,000,000 0 0 1,626,000,000 0 0 0 0 0 1,627,000,000
Reclassification of financial liabilities to other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Reclassification of other equity instruments to financial liabilities   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Transfers between total equity entries   0 0 0 0 1,902,000,000 (8,000,000) 41,000,000 0 (3,557,000,000) 1,621,000,000 0 0 0 0
Increase/Reduction of equity due to business combinations   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Share based payments   0 0 0 (22,000,000) 0 0 0 0 0 0 0 0 0 (22,000,000)
Other increases or (-) decreases in equity   0 0 0 22,000,000 9,000,000 0 (6,000,000) 0 0 (144,000,000) 0 0 (917,000,000) (1,035,000,000)
Balance at the end at Dec. 31, 2017 53,323,000,000 3,267,000,000 [1] 23,992,000,000 [1] 0 [1] 54,000,000 [1] 23,746,000,000 [1] 12,000,000 [1] (34,000,000) [1] (96,000,000) [1] 3,514,000,000 [1] (1,172,000,000) [1] (6,939,000,000) [1] (2,551,000,000) [1] 9,529,000,000 [1] 53,323,000,000 [1]
Changes in Equity Abstract                              
Adjustments Of Accounting Policies Applications   0 0 0 0 (2,579,000,000) 0 9,000,000 0 (5,000,000) (129,000,000) 1,756,000,000 850,000,000 (822,000,000) (919,000,000)
Of Which Prospective Changes In Accounting Policies [2]           (851,000,000) 0 0 0 0 0 (97,000,000) 23,000,000 7,000,000 (919,000,000)
Of which retrospective changes in accounting policies           (1,728,000,000) 0 9,000,000 0 (5,000,000) (129,000,000) 1,853,000,000 828,000,000 (828,000,000) 0
TOTAL RECOGNIZED INCOME/EXPENSES 3,704,000,000 0 0 0 0 0 0 0 0 5,400,000,000 0 (1,276,000,000) (1,247,000,000) 827,000,000 3,704,000,000
Changes in equity                              
Total Changes in Equity   0 0 0 (4,000,000) 180,000,000 (10,000,000) (23,000,000) (199,000,000) (3,514,000,000) 63,000,000 1,096,000,000 540,000,000 (1,364,000,000) (3,234,000,000)
Issue Of Equity   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuances of preferred shares   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuance of other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Period or maturity of other issued equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Conversion of debt on equity   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock reduction   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividend distribution   0 0 0 0 (992,000,000) 0 (4,000,000) 0 0 (1,109,000,000) 0 0 (378,000,000) (2,483,000,000)
Purchase of treasury shares   0 0 0 0 0 0 0 (1,684,000,000) 0 0 0 0 0 (1,684,000,000)
Sale or cancellation of treasury shares   0 0 0 0 (24,000,000) 0 0 1,484,000,000 0 0 0 0 0 1,460,000,000
Reclassification of financial liabilities to other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Reclassification of other equity instruments to financial liabilities   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Transfers between total equity entries   0 0 0 0 1,274,000,000 (10,000,000) (19,000,000) 0 (3,514,000,000) 1,172,000,000 1,096,000,000 540,000,000 (540,000,000) 0
Increase/Reduction of equity due to business combinations   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Share based payments   0 0 0 (19,000,000) 0 0 0 0 0 0 0 0 0 (19,000,000)
Other increases or (-) decreases in equity   0 0 0 15,000,000 (77,000,000) 0 0 0 0 0 0 0 (446,000,000) (508,000,000)
Balance at the end at Dec. 31, 2018 52,874,000,000 3,267,000,000 [3] 23,992,000,000 [3] 0 [3] 50,000,000 [3] 23,076,000,000 [3] 3,000,000 [3] (58,000,000) [3] (296,000,000) [3] 5,400,000,000 [3] (1,109,000,000) [3] (7,215,000,000) [3] (3,236,000,000) [3] 9,000,000,000 [3] 52,874,000,000 [3]
Changes in Equity Abstract                              
Adjustments Of Accounting Policies Applications   0 0 0 0 58,000,000 0 0 0 76,000,000 (134,000,000) 0 0 0 0
TOTAL RECOGNIZED INCOME/EXPENSES 4,036,000,000 0 0 0 0 0 0 0 0 3,512,000,000 0 (19,000,000) (291,000,000) 833,000,000 4,036,000,000
Changes in equity                              
Total Changes in Equity   0 0 0 6,000,000 3,327,000,000 (3,000,000) (68,000,000) 234,000,000 (5,400,000,000) 25,000,000 0 0 (106,000,000) (1,985,000,000)
Issue Of Equity   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuances of preferred shares   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuance of other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Period or maturity of other issued equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Conversion of debt on equity   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock reduction   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividend distribution   0 0 0 0 (1,059,000,000) 0 (4,000,000) 0 0 (1,084,000,000) 0 0 (142,000,000) (2,289,000,000)
Purchase of treasury shares   0 0 0 0 0 0 0 (1,088,000,000) 0 0 0 0 0 (1,088,000,000)
Sale or cancellation of treasury shares   0 0 0 0 13,000,000 0 0 1,322,000,000 0 0 0 0 0 1,335,000,000
Reclassification of financial liabilities to other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Reclassification of other equity instruments to financial liabilities   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Transfers between total equity entries   0 0 0 0 4,360,000,000 (3,000,000) (66,000,000) 0 (5,400,000,000) 1,109,000,000 0 0 0 0
Increase/Reduction of equity due to business combinations   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Share based payments   0 0 0 (4,000,000) 0 0 0 0 0 0 0 0 0 (4,000,000)
Other increases or (-) decreases in equity   0 0 0 11,000,000 14,000,000 0 1,000,000 0 0 0 0 0 36,000,000 62,000,000
Balance at the end at Dec. 31, 2019 € 54,925,000,000 € 3,267,000,000 [4] € 23,992,000,000 [4] € 0 [4] € 56,000,000 [4] € 26,402,000,000 [4] € 0 [4] € (125,000,000) [4] € (62,000,000) [4] € 3,512,000,000 [4] € (1,084,000,000) [4] € (7,235,000,000) [4] € (3,526,000,000) [4] € 9,727,000,000 [4] € 54,925,000,000 [4]
[1]

(*) Balances as of December 31, 2016 as originally reported in the consolidated Financial Statements for the year 2016.

[2]

(**) The balance as of January 1 , 2018, is the adjusted initial balance less the prospective changes in accounting

[3]

(*) Balances as of December 31, 2017 as originally reported in the consolidated Financial Statements for the year 2017.

[4]

(*) Balances as of December 31, 2018 as originally reported in the consolidated Financial Statements for the year 2018.